Deleted Tweets From Scott Gottlieb, R-D.C.

Using SNOMED CT will help @US_FDA to better identify areas of unmet needs in drug development as well as inform policy development, helping to encourage greater advances in medicine. Learn more: https://t.co/TSgiCov3Tn 3/3

FDA public workshop May 9, 2018 on Tissue Agnostic Therapies and Regulatory Considerations for Orphan Drug Designation https://t.co/9UNAuF36q4

Perhaps no dietary advance, no single new medical product, and no new enforcement steps; could have the same profound public health impact as our ability to dramatically lower smoking rates in this country. I outline our public health approach at #FDLI201

RT @FDATobacco: Parents and other caregivers can help protect children from accidental exposure to e-liquids by following some simp… https://t.co/FWMdX1Q9g6

Starting Monday, consumers will see calorie counts on menus in large chain restaurants; research shows this could reduce orders by 30 to 50 calories per visit. Studies show these reductions could help prevent obesity. https://t.co/57hJ1xcdAE https://t.co/

RT @califf001: Important quantitative support for minimizing nicotine in cigs. @dukeforge Potential Public Health Effects of Redu… https://t.co/mGjt0TMt7w

#FDAOncology continues to take new steps to advance cancer drug development: Join their Public Workshop: 2018 Clinical Outcome Assessments in Cancer Clinical Trials June 22, 2018 #OCEOutcomes #OCEPFDD #PRO https://t.co/hx8chlGBXs

#FDAOncology with @ASCO and @CancerResrch working to encourage clinical trial sponsors to broaden eligibility criteria; perspective and articles in @JCO_ASCO https://t.co/J2YYdW96eT

RT @FDAfood: Nurses, thanks for all you do! We especially appreciate the role you play in promoting nutritional health.… https://t.co/b7hjVzysSo

The public health dedication, clinical devotion, and moral fiber that binds together the professional staff of #FDA, personified one tweet at a time. https://t.co/353aWHafaW QT @tmprowell: I was an IM resident rotating in rural Zambia. You a 2 yr old seizing nonstop in your village. I held you in an ox-… https://t.co/r0aZyugefl)

My remarks from this week outlining some of the new steps #FDA is taking to promote drug competition and innovation; making the new drug development process more efficient, predictable #FDLI2018 https://t.co/OQTXkDEZCd

FDA will be taking additional enforcement actions in the coming weeks and months to protect children from tobacco products. No youth should use any tobacco product. That includes e-cigs. We’ll target those who target kids. https://t.co/j8MKU4PXz6

RT @FDAOncology: Join us in person or online June 22 for #FDAOncology workshop on clinical outcome assessments in cancer clinical tr… https://t.co/VVfkdePGyY

#FDA will also issue final guidance to provide greater clarity and certainty to chain restaurants on how they can meet the new menu labeling provisions. We’ve taken steps to make sure that restaurants can meet these requirements efficiently; to maximize t

#FDA will be building on our recent enforcement actions targeting the youth use of e-cigarettes. In the coming weeks, we’ll be taking new actions. No child should be using any tobacco product, and no tobacco product should be sold or marketed to children

Tomorrow #FDA’s new menu labeling requirements for chain restaurants go into effect. FDA will spend the first year helping covered restaurants efficiently come into compliance to make sure that the new provisions are maximally beneficial for consumers htt

#FDA will announce additional steps this week, as part of its comprehensive Youth Tobaccco Prevention Plan, to target companies who market or sell e-cigarette products to children https://t.co/EQxMbitgeT

RT @juliaoftoronto: .@SGottliebFDA's framing of calorie labeling on menus — an Obama-era reg — is really interesting. He's repeatedly s… https://t.co/WQsumQmu1x

RT @MorningEdition: This week, the FDA plans to roll out new enforcement actions against companies that sell vape pens and accessories… https://t.co/vRRcL1Ndfs

#FDA, CDC and partners continue investigating the E. coli outbreak linked to romaine. Read our “FDA Fast Facts” for key information https://t.co/0PtDJPgYff

RT @FDAJobs: Learn about FDA's hiring redesign from the Acting Associate Commissioner for Scientific and Clinical Recruitment https://t.co/c23PchB4xj

RT @FDAMedia: Statement from @SGottliebFDA on public health benefits of enactment of menu labeling & marking of May 7 compliance… https://t.co/SlvqdDkosN

RT @FDA_Drug_Info: Join @FDAWomen on May 16 from 1-2:30p EST for “The Great Debate” to learn about the challenges and complexity of “W… https://t.co/nPs3PUKgVH

RT @US_FDA: Menu labeling is part of a broader multi-year Nutrition Innovation Strategy providing all Americans with easier acc… https://t.co/N0Tsw7fOhs

Romaine lettuce is no longer being distributed from the Yuma growing region so the potential for additional exposure to contaminated product is diminished. We will keep working to find the source of this outbreak https://t.co/0PtDJPgYff

RT @US_FDA: Visit our Flickr album for examples of signage consumers can expect to see at restaurants as FDA’s new menu labelin… https://t.co/VSmAUjL13k

@daviesbj There’s no such thing as a free lunch @daviesbj

#FDA’s new menu labeling provision will provide a level playing field for basic health information that will help promote more competition to make menu items more healthful https://t.co/qf4qV9jeZl

People in the U.S. currently eat about 1/3 of their calories away from home. Research suggests that people order menu items with fewer calories when they have access to calorie information. Discover how FDA is making that info available to you. https://t.

#FDA’s new “Predictive #Toxicology Roadmap” aims to advance technology that can improve tox testing, reduce reliance on animal studies, and lower drug development costs. Sign up for #FDAGrandRounds May 10 by Dr. Suzanne Fitzpatrick. #Organs-on-a-Chip htt

The Hill Op Ed: “With uniform national menu labeling guidance in place, anyone eating out will have clear, easy-to-understand information at the point of ordering – information that is presented in the same way, no matter the city or state.” https://t.co/

RT @MorningEdition: The FDA is cracking down on the sale of vape pens to teens, FDA Commissioner @SGottliebFDA tells @rachelnpr.… https://t.co/PZ6lCqN3Wk

E-cigarettes present an opportunity for adults who want to quit combustible tobacco but still access satisfying levels of nicotine. But at the same time #FDA works to make e-cigs available to adults; we can’t let a generation of kids get hooked on them ht

RT @FDATobacco: � We’ve updated the FDA Age Calculator mobile app so that tobacco retailers who use the app can set the minimum age… https://t.co/wigSaUnVEh

#FDA is taking new steps to make its hiring processes more efficient to improve our recruitment of new talent into the agency. Our strength is the skill and experience of our dedicated, professional workforce https://t.co/WikjgRp0b7

Follow us at @FDAJobs for the latest on new opportunities at #FDA. You want to make a difference. FDA wants to hire you! Follow us on here and check out https://t.co/h7SUD5mjDF

RT @mcipriano93: US FDA Hiring For Senior Staff Vacancies Boosted By Cures Act, Pilot Program – Gottlieb https://t.co/BkqVfJeMab

RT @MedResJourno: @SGottliebFDA is asking Congress for $100M for a real-time, #EHR monitoring program, which he said could help set d… https://t.co/jlbhc641jC

RT @FDAWomen: Read our new journal article, Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular D… https://t.co/7MGKgV0Xnw

#FDA’s proceeding in a step-wise fashion to ensure actions re: OTC loperamide use are reasonable & scientifically sound. These actions are necessary to address issues of abuse/misuse, and achieve safe use of the drug while maintaining access for patie

My comments on #FDA’s updated activities aimed at stemming the abuse of loperamide while maintaining access for appropriate patients who rely on this medicine https://t.co/emjI4SKBf6

We’re aware that those suffering from opioid addiction see loperamide as a potential alternative to manage opioid withdrawal symptoms or to achieve euphoric effects. But at very high doses, this drug is dangerous and #FDA must address abuse/misuse issues:

My comments on the new regulations that #FDA intends to pursue as part of the Administration’s unified agenda, which was released today https://t.co/Ixfg54Nwa4

RT @NCCNnews: Join us next month to hear what @SGottliebFDA and others have to say about the "New Normal" in Health Care >>… https://t.co/lczkSO1cJq

As with other new patterns of abuse and misuse related to the opioid crisis, #FDA acted with urgency to address the issues related to loperamide by revising labeling, encouraging packaging changes and asking online sellers to stop selling large quantities

RT @BioCentury: FDA planning guidance on designations for tissue agnostic therapies https://t.co/I2uLLBOuAv

Today @TheJusticeDept and #FDA filed complaints against two stem cell clinics for disregarding the law and more importantly, patient safety. We cannot allow unproven products that exploit the hope of patients and their loved ones. https://t.co/Aa7KFjZSl3

The complaints are seeking permanent injunctions to stop the two stem cell clinics from marketing stem cell products without @US_FDA approval and to halt their significant deviations from current good manufacturing practice requirements. https://t.co/Aa7K

RT @rickberke: Most aggressive crackdown on stem cell clinics in years. https://t.co/UpU11B9CO6 QT @DrewQJoseph: In significant action from @US_FDA today, agency moves to stop stem cell treatments at 2 notorious clinics. Agency… https://t.co/TDee6uNAFd)

#FDA will continue to take enforcement actions against stem cell clinics that abuse the trust of patients and endanger their health. https://t.co/Aa7KFjZSl3

Using SNOMED CT will help @US_FDA to better identify areas of unmet needs in drug development as well as inform policy development, helping to encourage greater advances in medicine. Learn more: https://t.co/TSgiCov3Tn 3/3

FDA public workshop May 9, 2018 on Tissue Agnostic Therapies and Regulatory Considerations for Orphan Drug Designation https://t.co/9UNAuF36q4

Perhaps no dietary advance, no single new medical product, and no new enforcement steps; could have the same profound public health impact as our ability to dramatically lower smoking rates in this country. I outline our public health approach at #FDLI201

RT @FDATobacco: Parents and other caregivers can help protect children from accidental exposure to e-liquids by following some simp… https://t.co/FWMdX1Q9g6

Starting Monday, consumers will see calorie counts on menus in large chain restaurants; research shows this could reduce orders by 30 to 50 calories per visit. Studies show these reductions could help prevent obesity. https://t.co/57hJ1xcdAE https://t.co/

RT @califf001: Important quantitative support for minimizing nicotine in cigs. @dukeforge Potential Public Health Effects of Redu… https://t.co/mGjt0TMt7w

#FDAOncology continues to take new steps to advance cancer drug development: Join their Public Workshop: 2018 Clinical Outcome Assessments in Cancer Clinical Trials June 22, 2018 #OCEOutcomes #OCEPFDD #PRO https://t.co/hx8chlGBXs

#FDAOncology with @ASCO and @CancerResrch working to encourage clinical trial sponsors to broaden eligibility criteria; perspective and articles in @JCO_ASCO https://t.co/J2YYdW96eT

RT @FDAfood: Nurses, thanks for all you do! We especially appreciate the role you play in promoting nutritional health.… https://t.co/b7hjVzysSo

The public health dedication, clinical devotion, and moral fiber that binds together the professional staff of #FDA, personified one tweet at a time. https://t.co/353aWHafaW QT @tmprowell: I was an IM resident rotating in rural Zambia. You a 2 yr old seizing nonstop in your village. I held you in an ox-… https://t.co/r0aZyugefl)

My remarks from this week outlining some of the new steps #FDA is taking to promote drug competition and innovation; making the new drug development process more efficient, predictable #FDLI2018 https://t.co/OQTXkDEZCd

FDA will be taking additional enforcement actions in the coming weeks and months to protect children from tobacco products. No youth should use any tobacco product. That includes e-cigs. We’ll target those who target kids. https://t.co/j8MKU4PXz6

RT @FDAOncology: Join us in person or online June 22 for #FDAOncology workshop on clinical outcome assessments in cancer clinical tr… https://t.co/VVfkdePGyY

#FDA will also issue final guidance to provide greater clarity and certainty to chain restaurants on how they can meet the new menu labeling provisions. We’ve taken steps to make sure that restaurants can meet these requirements efficiently; to maximize t

#FDA will be building on our recent enforcement actions targeting the youth use of e-cigarettes. In the coming weeks, we’ll be taking new actions. No child should be using any tobacco product, and no tobacco product should be sold or marketed to children

Tomorrow #FDA’s new menu labeling requirements for chain restaurants go into effect. FDA will spend the first year helping covered restaurants efficiently come into compliance to make sure that the new provisions are maximally beneficial for consumers htt

#FDA will announce additional steps this week, as part of its comprehensive Youth Tobaccco Prevention Plan, to target companies who market or sell e-cigarette products to children https://t.co/EQxMbitgeT

RT @juliaoftoronto: .@SGottliebFDA's framing of calorie labeling on menus — an Obama-era reg — is really interesting. He's repeatedly s… https://t.co/WQsumQmu1x

RT @MorningEdition: This week, the FDA plans to roll out new enforcement actions against companies that sell vape pens and accessories… https://t.co/vRRcL1Ndfs

#FDA, CDC and partners continue investigating the E. coli outbreak linked to romaine. Read our “FDA Fast Facts” for key information https://t.co/0PtDJPgYff

RT @FDAJobs: Learn about FDA's hiring redesign from the Acting Associate Commissioner for Scientific and Clinical Recruitment https://t.co/c23PchB4xj

RT @FDAMedia: Statement from @SGottliebFDA on public health benefits of enactment of menu labeling & marking of May 7 compliance… https://t.co/SlvqdDkosN

RT @FDA_Drug_Info: Join @FDAWomen on May 16 from 1-2:30p EST for “The Great Debate” to learn about the challenges and complexity of “W… https://t.co/nPs3PUKgVH

RT @US_FDA: Menu labeling is part of a broader multi-year Nutrition Innovation Strategy providing all Americans with easier acc… https://t.co/N0Tsw7fOhs

Romaine lettuce is no longer being distributed from the Yuma growing region so the potential for additional exposure to contaminated product is diminished. We will keep working to find the source of this outbreak https://t.co/0PtDJPgYff

RT @US_FDA: Visit our Flickr album for examples of signage consumers can expect to see at restaurants as FDA’s new menu labelin… https://t.co/VSmAUjL13k

@daviesbj There’s no such thing as a free lunch @daviesbj

#FDA’s new menu labeling provision will provide a level playing field for basic health information that will help promote more competition to make menu items more healthful https://t.co/qf4qV9jeZl

People in the U.S. currently eat about 1/3 of their calories away from home. Research suggests that people order menu items with fewer calories when they have access to calorie information. Discover how FDA is making that info available to you. https://t.

#FDA’s new “Predictive #Toxicology Roadmap” aims to advance technology that can improve tox testing, reduce reliance on animal studies, and lower drug development costs. Sign up for #FDAGrandRounds May 10 by Dr. Suzanne Fitzpatrick. #Organs-on-a-Chip htt

The Hill Op Ed: “With uniform national menu labeling guidance in place, anyone eating out will have clear, easy-to-understand information at the point of ordering – information that is presented in the same way, no matter the city or state.” https://t.co/

RT @MorningEdition: The FDA is cracking down on the sale of vape pens to teens, FDA Commissioner @SGottliebFDA tells @rachelnpr.… https://t.co/PZ6lCqN3Wk

E-cigarettes present an opportunity for adults who want to quit combustible tobacco but still access satisfying levels of nicotine. But at the same time #FDA works to make e-cigs available to adults; we can’t let a generation of kids get hooked on them ht

RT @FDATobacco: � We’ve updated the FDA Age Calculator mobile app so that tobacco retailers who use the app can set the minimum age… https://t.co/wigSaUnVEh

#FDA is taking new steps to make its hiring processes more efficient to improve our recruitment of new talent into the agency. Our strength is the skill and experience of our dedicated, professional workforce https://t.co/WikjgRp0b7

Follow us at @FDAJobs for the latest on new opportunities at #FDA. You want to make a difference. FDA wants to hire you! Follow us on here and check out https://t.co/h7SUD5mjDF

RT @mcipriano93: US FDA Hiring For Senior Staff Vacancies Boosted By Cures Act, Pilot Program – Gottlieb https://t.co/BkqVfJeMab

RT @MedResJourno: @SGottliebFDA is asking Congress for $100M for a real-time, #EHR monitoring program, which he said could help set d… https://t.co/jlbhc641jC

RT @FDAWomen: Read our new journal article, Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular D… https://t.co/7MGKgV0Xnw

#FDA’s proceeding in a step-wise fashion to ensure actions re: OTC loperamide use are reasonable & scientifically sound. These actions are necessary to address issues of abuse/misuse, and achieve safe use of the drug while maintaining access for patie

My comments on #FDA’s updated activities aimed at stemming the abuse of loperamide while maintaining access for appropriate patients who rely on this medicine https://t.co/emjI4SKBf6

We’re aware that those suffering from opioid addiction see loperamide as a potential alternative to manage opioid withdrawal symptoms or to achieve euphoric effects. But at very high doses, this drug is dangerous and #FDA must address abuse/misuse issues:

My comments on the new regulations that #FDA intends to pursue as part of the Administration’s unified agenda, which was released today https://t.co/Ixfg54Nwa4

RT @NCCNnews: Join us next month to hear what @SGottliebFDA and others have to say about the "New Normal" in Health Care >>… https://t.co/lczkSO1cJq

As with other new patterns of abuse and misuse related to the opioid crisis, #FDA acted with urgency to address the issues related to loperamide by revising labeling, encouraging packaging changes and asking online sellers to stop selling large quantities

RT @BioCentury: FDA planning guidance on designations for tissue agnostic therapies https://t.co/I2uLLBOuAv

Today @TheJusticeDept and #FDA filed complaints against two stem cell clinics for disregarding the law and more importantly, patient safety. We cannot allow unproven products that exploit the hope of patients and their loved ones. https://t.co/Aa7KFjZSl3

The complaints are seeking permanent injunctions to stop the two stem cell clinics from marketing stem cell products without @US_FDA approval and to halt their significant deviations from current good manufacturing practice requirements. https://t.co/Aa7K

RT @rickberke: Most aggressive crackdown on stem cell clinics in years. https://t.co/UpU11B9CO6 QT @DrewQJoseph: In significant action from @US_FDA today, agency moves to stop stem cell treatments at 2 notorious clinics. Agency… https://t.co/TDee6uNAFd)

#FDA will continue to take enforcement actions against stem cell clinics that abuse the trust of patients and endanger their health. https://t.co/Aa7KFjZSl3